UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000019221
Receipt No. R000022213
Official scientific title of the study Observational study on the tinnitus and hyperacusis in patients with acute sensorineural hearing loss
Date of disclosure of the study information 2015/10/15
Last modified on 2017/04/01 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Observational study on the tinnitus and hyperacusis in patients with acute sensorineural hearing loss
Title of the study (Brief title) Observational study on the tinnitus and hyperacusis in patients with acute sensorineural hearing loss
Region
Japan

Condition
Condition tinnitus
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 observation of the appearance of tinnitus in patients with acute sensorineural hearing loss
Basic objectives2 Others
Basic objectives -Others Diachronic evaluation of the symptoms
Trial characteristics_1 Exploratory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes score of THI (tinnitus handicap inventory)
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) patients with acute sensorineural hearing loss within two weeks after onset
2) voluntary participants
3) age >= 20 years old
4) Peformance status = 0 or 1
Key exclusion criteria 1) Peripheral or central neurological diorders
2) Past history of the mental disease
3) Possiblity of the pregnancy
4) Possible participants whom it is judged to be inappropriate as a subjects
Target sample size 200

Research contact person
Name of lead principal investigator Tetsuaki Kawase
Organization Tohoku University Graduate School of Biomedical Engineering / Graduate School of Medicine
Division name audiology
Address 1-1 Seiryo-machi, Aoba-ku, Sendai
TEL 022-717-7303
Email kawase@orl.med.tohoku.ac.jp

Public contact
Name of contact person Tetsuaki Kawase
Organization Tohoku University Graduate School of Biomedical Engineering / Graduate School of Medicine
Division name audiology
Address 1-1 Seiryo-machi, Aoba-ku, Sendai
TEL 022-717-7303
Homepage URL
Email kawase@orl.med.tohoku.ac.jp

Sponsor
Institute Tohoku University
Institute
Department

Funding Source
Organization Tohoku University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 15 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 10 Month 01 Day
Anticipated trial start date
2015 Year 10 Month 15 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results Termninated
Other related information Study Design: cohort study
Subjects: all that meet the selection criteria among the patients admitted to the hospital to participate in the present study.
Measurement items: questionnaire and VAS (visual analogue scale) for the assessment of tinnitus and hyperacusis. hyperacusis.September 2018.
Follow-up period: 1 year.

Management information
Registered date
2015 Year 10 Month 03 Day
Last modified on
2017 Year 04 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022213